Search research articles
Contact Us
Filters
Showing results (441-450 of 604) with videos related to
Page
of 61
Sort By:
JCO Clinical Cancer Informatics
|
January 25, 2020
Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence
George Tran, Matthew Harker, Karen Chiswell, et al.
Molecular and Cellular Pharmacology
|
April 21, 2015
Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation
Janeen H Trembley, Gretchen M Unger, Omar Cespedes Gomez, et al.
Cancer Research Communications
|
September 14, 2023
Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation
Riha Vaidya, Joseph M Unger, Rohit Loomba, et al.
American Journal of Preventive Medicine
|
September 23, 2019
Hepatitis B Birth Dose: First Shot at Timely Early Childhood Vaccination
Natalia V Oster, Emily C Williams, Joseph M Unger, et al.
JAMA Oncology
|
August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018
Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
Vaccine
|
April 2, 2019
Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State
Natalia V Oster, Emily C Williams, Joseph M Unger, et al.
Journal of the National Cancer Institute
|
January 16, 1991
Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma
C R Divgi, S Welt, M Kris, et al.
JCO Oncology Practice
|
July 13, 2021
Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials
Julia Mo, Amy K Darke, Katherine A Guthrie, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 9, 2016
Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702
Catherine H Van Poznak, Amy Darke, Carol M Moinpour, et al.
Blood
|
June 27, 2012
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
Page
of 61
Search research articles
Search
Showing results (441-450 of 604) with videos related to
Sort By:
Page
of 61
JCO Clinical Cancer Informatics
|
January 25, 2020
Feasibility of Cancer Clinical Trial Enrollment Goals Based on Cancer Incidence
George Tran, Matthew Harker, Karen Chiswell, et al.
Molecular and Cellular Pharmacology
|
April 21, 2015
Tenfibgen-DMAT Nanocapsule Delivers CK2 Inhibitor DMAT to Prostate Cancer Xenograft Tumors Causing Inhibition of Cell Proliferation
Janeen H Trembley, Gretchen M Unger, Omar Cespedes Gomez, et al.
Cancer Research Communications
|
September 14, 2023
Universal Viral Screening of Patients with Newly Diagnosed Cancer in the United States: A Cost-efficiency Evaluation
Riha Vaidya, Joseph M Unger, Rohit Loomba, et al.
American Journal of Preventive Medicine
|
September 23, 2019
Hepatitis B Birth Dose: First Shot at Timely Early Childhood Vaccination
Natalia V Oster, Emily C Williams, Joseph M Unger, et al.
JAMA Oncology
|
August 16, 2019
Disparity of Race Reporting and Representation in Clinical Trials Leading to Cancer Drug Approvals From 2008 to 2018
Jonathan M Loree, Seerat Anand, Arvind Dasari, et al.
Vaccine
|
April 2, 2019
Sociodemographic, clinical and birth hospitalization characteristics and infant Hepatitis B vaccination in Washington State
Natalia V Oster, Emily C Williams, Joseph M Unger, et al.
Journal of the National Cancer Institute
|
January 16, 1991
Phase I and imaging trial of indium 111-labeled anti-epidermal growth factor receptor monoclonal antibody 225 in patients with squamous cell lung carcinoma
C R Divgi, S Welt, M Kris, et al.
JCO Oncology Practice
|
July 13, 2021
Association of Fatigue and Outcomes in Advanced Cancer: An Analysis of Four SWOG Treatment Trials
Julia Mo, Amy K Darke, Katherine A Guthrie, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer
|
December 9, 2016
Dental health status and patient-reported outcomes at baseline in patients participating in the osteonecrosis of the jaw registry study, SWOG S0702
Catherine H Van Poznak, Amy Darke, Carol M Moinpour, et al.
Blood
|
June 27, 2012
A phase 2 trial of standard-dose cyclophosphamide, doxorubicin, vincristine, prednisone (CHOP) and rituximab plus bevacizumab for patients with newly diagnosed diffuse large B-cell non-Hodgkin lymphoma: SWOG 0515
Alison T Stopeck, Joseph M Unger, Lisa M Rimsza, et al.
Page
of 61